-
2 weeks ago | 
outsourcedpharma.com | Yves Massicotte |Nathan Dormer |Louis Garguilo |David Lyon
20-minute capacity and capabilities quick-looks, 20+ brand new CDMO presenters to evaluate for best-fit this quarter – and a (virtual) commitment of less than 20 percent of your day? We’re confident you don’t need 20/20 vision to see the value in this! Join us for Outsourced Pharma’s July Partner Week – including sessions in Small Molecule API/HPAPI, Small Molecule Finished Dosage Form, ADC, Analytical Services, and Fill/Finish among others.
-
3 weeks ago | 
outsourcedpharma.com | Xiaojun Liu |Yeonji Kim |Chris Brown |Jing Zhu |Louis Garguilo
By Xiaojun Liu, Yeonji Kim, Chris Brown, and Jing Zhu
Recombinant adeno-associated virus (rAAV) vectors are pivotal in gene therapy due to their proven safety and efficacy for therapeutic gene delivery. However, low production yields and vector heterogeneity remain significant barriers to scalable, high-quality manufacturing.
-
1 month ago | 
outsourcedpharma.com | John Atkinson |FUJIFILM Diosynth Biotechnologies |Louis Garguilo
By John Atkinson, Global Head of Information Security Office, FUJIFILM Diosynth Biotechnologies
Drug developers are under increasing pressure to reduce the cost and time of bringing new medicines to market amidst growing complexities in drug modalities. Automation and digitalization, proven catalysts in sectors like automotive and advanced manufacturing, offer solutions.
-
2 months ago | 
outsourcedpharma.com | Brian James |Louis Garguilo
Guest Column
| April 24, 2025
By Brian James, Outsourced Pharma Advisory Board Member
Pharmaceutical procurement shares consistencies across companies, and the decision to contract with other parties can depend on price, geography, expertise, and other variables. However, while price is often a key motivation for the decision, it’s production cost that should be carefully considered.
-
2 months ago | 
outsourcedpharma.com | Dustin Williams |Louis Garguilo |Sabine Gölden |David Lyon
Webinar: 3D Screen Printing: Breakthrough Solutions for Patient-Centric TherapiesThis webinar explores 3D screen printing in pharmaceutical manufacturing, a breakthrough overcoming scalability and formulation challenges of traditional 3D printing. It enables precise layering for multi-functional tablets with customizable drug release profiles, enhancing efficacy and patient convenience.
-
Mar 25, 2025 | 
outsourcedpharma.com | Louis Garguilo
Contract manufacturing and packaging services that bring your vision to market.
Ropack is a leading provider of turnkey contract packaging and manufacturing services for the pharmaceutical and consumer healthcare industries. Flexible, agile and competitive, we deliver a full scope of services, all focused on reliably accelerating your go-to-market timeline.
-
Mar 25, 2025 | 
outsourcedpharma.com | Louis Garguilo
A Revolutionary AI-Powered Inspection System for Pharmaceutical Manufacturing
Verista, a leading provider of automation, compliance, and quality solutions for the pharmaceutical industry, highlights the COUNTQ Tray Inspection System, an advanced AI-enabled inspection and reconciliation system designed to revolutionize the counting and verification of vials, syringes, ampoules, and other tray-loaded parts in pharmaceutical manufacturing.
-
Mar 24, 2025 | 
outsourcedpharma.com | Louis Garguilo
Explore how shifting demand for oligos and peptides is driving outsourcing relationships and innovation in CDMO partnerships. Join our next Outsourced Pharma Live as we cover best practices for outsourcing these specialized therapeutics, focusing on capacity, regulatory challenges, and technology transfer. Register today to learn about the unique challenges and opportunities in scaling production for these complex molecules.
-
Mar 24, 2025 | 
outsourcedpharma.com | Louis Garguilo
Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), is proud to announce its selection as Champion Winner in the Small Molecule Dosage Form – International category at the 2025 CDMO Leadership Awards.
-
Mar 22, 2025 | 
outsourcedpharma.com | Louis Garguilo
In the dynamic world of biologics manufacturing, change remains one of the few constants. As new modalities and innovations continuously emerge, the future holds promising prospects for patients. However, manufacturers face the challenge of keeping pace with these advancements and determining the best areas for investment. Amidst these changes, another significant trend is gaining serious momentum: sustainability.
